Variational Autoencoders for Cancer Data Integration: Design Principles and Computational Practice. by Simidjievski, Nikola et al.
1Edited by: 
Davide Chicco, 
Peter Munk Cardiac Centre, 
Canada
Reviewed by: 
Emanuel Weitschek, 
Università Telematica Internazionale 
Uninettuno, 
Italy 
 Samir B. Amin, 
Jackson Laboratory for Genomic 
Medicine, United States
*Correspondence: 
 Nikola Simidjievski 
nikola.simidjievski@cl.cam.ac.uk
†These authors have contributed 
equally to this work
Specialty section: 
This article was submitted 
to Bioinformatics and 
Computational Biology, 
 a section of the journal 
 Frontiers in Genetics
Received: 29 July 2019
Accepted: 31 October 2019
Published: 11 December 2019
Citation: 
Simidjievski N, Bodnar C, Tariq I, 
Scherer P, Andres Terre H, Shams Z, 
Jamnik M and Liò P (2019) Variational 
Autoencoders for Cancer Data 
Integration: Design Principles and 
Computational Practice. 
 Front. Genet. 10:1205. 
 doi: 10.3389/fgene.2019.01205
Variational Autoencoders for Cancer 
Data Integration: Design Principles 
and Computational Practice
Nikola Simidjievski 1†*, Cristian Bodnar 1†, Ifrah Tariq 1,2†, Paul Scherer 1,  
Helena Andres Terre 1, Zohreh Shams 1, Mateja Jamnik 1 and Pietro Liò 1
1 Department of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom, 2 Department of 
Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States
International initiatives such as the Molecular Taxonomy of Breast Cancer International 
Consortium are collecting multiple data sets at different genome-scales with the aim 
to identify novel cancer bio-markers and predict patient survival. To analyze such data, 
several machine learning, bioinformatics, and statistical methods have been applied, 
among them neural networks such as autoencoders. Although these models provide 
a good statistical learning framework to analyze multi-omic and/or clinical data, there is 
a distinct lack of work on how to integrate diverse patient data and identify the optimal 
design best suited to the available data.In this paper, we investigate several autoencoder 
architectures that integrate a variety of cancer patient data types (e.g., multi-omics 
and clinical data). We perform extensive analyses of these approaches and provide a 
clear methodological and computational framework for designing systems that enable 
clinicians to investigate cancer traits and translate the results into clinical applications. 
We demonstrate how these networks can be designed, built, and, in particular, applied 
to tasks of integrative analyses of heterogeneous breast cancer data. The results show 
that these approaches yield relevant data representations that, in turn, lead to accurate 
and stable diagnosis.
Keywords: machine learning, cancer–breast cancer, variational autoencoder, deep learning, integrative data 
analyses, artificial intelligence, bioinformactics, multi-omic analysis
INTRODUCTION
The rapid technological developments in cancer research yield large amounts of complex 
heterogeneous data on different scales—from molecular to clinical and radiological data. The 
limited number of samples that can be collected are usually noisy, incompletely annotated, sparse, 
and high-dimensional (many variables). As much as these high-throughput data acquisition 
approaches challenge the data-to-discovery process, they drive the development of new sophisticated 
computational methods for data analysis and interpretation. In particular, the synergy of cancer 
research and machine learning has led to groundbreaking discoveries in diagnosis, prognosis, 
and treatment planning for cancer patients (Vial et al., 2018; Levine et al., 2019). Typically, such 
machine learning methods are developed to address particular complexities inherent in individual 
data types, separately. While relevant, this approach is sub-optimal since it fails to exploit the inter-
dependencies between the different data silos, and is thus often not extendable to analyzing and 
modeliing more complex biological phenomena (Gomez-Cabrero et al., 2014; Hériché et al., 2019).
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To capitalize on the inter-dependencies and relations across 
heterogeneous types of data about each patient (Yuan et al., 
2011; Miotto et al., 2016), integrating multiple types and sources 
of data is essential. The data-integration paradigm focuses on 
a fundamental concept—that a complex biological process is a 
combination of many simpler processes and its function is greater 
than the sum of its parts. Hence, integrating and simultaneously 
analyzing different data types offers better understanding of the 
mechanisms of a biological process and its intrinsic structure. 
Many studies have addressed and highlighted the importance 
of data integration at different scales (Gomez-Cabrero et al., 
2014; Huang et al., 2017; Karczewski and Snyder, 2018; López 
de Maturana et al., 2019; Žitnik et al., 2019). In the context of 
analyzing cancer data, it has been shown that such integrative 
approaches yield improved performance for accurate diagnosis, 
survival analysis, and treatment planning (Shen et al., 2009; 
Kristensen et al., 2014; Thomas et al., 2014; Gevaert et al., 2016; 
Vial et al., 2018). In particular, Wang et al. (2014) show that, 
for the case of five different cancer profiles, integrating mRNA 
expression, DNA methylation, and miRNA data leads to more 
accurate survival profiles than each of the individual types of 
data alone. These findings are in line with the ones of (Amin 
et al., 2014), where the authors point out that gene expression 
profiles alone are sub-optimal for predicting complete response 
in patients with multiple myeloma.
In this paper we design and systematically analyze several deep-
learning approaches for data integration based on Variational 
Autoencoders (VAEs) (Kingma and Welling, 2014). VAEs 
provide an unsupervised methodology for generating meaningful 
(disentangled) latent representations of integrated data. Such 
approaches can be utilized in two ways. First, the generated latent 
representations of integrated data can be exploited for analysis by 
any machine learning technique. Second, our architectures can 
be deployed on other heterogeneous data sets. We illustrate the 
functionality and benefit of the designed approaches by applying 
them to cancer data—this paves the way to improve survival 
analysis and bio-marker discovery.
There are several existing machine learning approaches that 
integrate diverse data. These can be classified into three different 
categories based on how the data is being utilized (Pavlidis et al., 
2002; Gevaert et al., 2006): (i) output (or late) integration, (ii) partial 
(or intermediate) integration, and (iii) full (or early) integration. 
Output integration relates to methods that model different data 
separately, the output of which is subsequently combined (Gevaert 
et al., 2006; Yang et al., 2010; Qi, 2012). Partial integration refers 
to specifically designed and developed methods that produce a 
joint model learned from multiple data simultaneously (Gevaert et 
al., 2006; Wang et al., 2014; Žitnik and Zupan, 2015). Finally, full-
integration approaches focus on combining different data before 
applying a learning algorithm, either by simply aggregating them 
or learning a common latent representation (Shen et al., 2009; 
Bengio et al., 2013). Our work presented here falls into this third 
category, namely full (or early) integration.
Recently, many deep learning approaches have been proposed 
for analyzing cancer data (Levine et al., 2019). Typically, they rely 
on extracting valuable features using deep convolutional neural 
networks for analyzing and classifying tasks of radiological data 
(Ardila et al., 2019; Esteva et al., 2019). However, these methods 
often relate to supervised learning, and require many labeled 
observations in order to perform well. In contrast, unsupervised 
approaches learn representations by identifying patterns in the 
data and extracting meaningful knowledge while overcoming 
data complexities. Particular variants of deep learning networks, 
referred to as autoencoders, have demonstrated good performance 
for unsupervised representation learning (Bengio et al., 2013).
Autoencoders learn a compressed representation (embedding/
code) of the input data by reconstructing it on the output of the 
network. The hope is that such a compressed representation captures 
the structure of the data (i.e., intrinsic relationships between the 
data variables) and therefore allows for more accurate downstream 
analyses (Belkin and Niyogi, 2003). Autoencoders have been 
deployed on a variety of tasks across different data types such as 
dimensionality reduction, data denoising, compression, and data 
generation. In the context of cancer data integration, several studies 
highlighted their utility in combining data on different scales for 
identifying prognostic cancer traits such as liver (Chaudhary 
et al., 2018), breast (Tan et al., 2015) and neuroblastoma cancer 
(Zhang et al., 2018) sub-types. The focus of these studies is to apply 
autoencoders to specific problems of cancer-data integration.
In contrast, in this paper we investigate approaches that build 
upon probabilistic autoencoders which implement Variational 
Bayesian inference for unsupervised learning of latent data 
representations. Instead of only learning a compressed 
representation of the input data, VAEs learn the parameters 
of the underlying distribution of the input data. VAEs can be 
utilized as methods for full/early integration of data: this allows 
for learning representations from heterogeneous data on different 
scales from different sources. In this paper we mainly focus on 
the data integration aspect, so we utilize VAEs together with 
other sophisticated machine learning methods for modeling and 
analyzing breast cancer data. We perform a systematic evaluation 
(we evaluate 1296 different network configurations) of different 
aspects of data integration based on VAEs. We investigate and 
evaluate four different integrative VAE architectures and their 
components. We analyze and demonstrate their functionality 
by integrating multi-omics and clinical data for different breast-
cancer analysis tasks on data from the Molecular Taxonomy of 
Breast Cancer International Consortium (METABRIC) cohort. 
In summary, the contribution of this paper is two-fold: (i) novel 
architectures for integrating data; and (ii) methodologies for 
choosing architectures that best suit the data in hand.
MATeRIAls AND MeThODs
Many machine learning methodologies have been applied to 
cancer medicine to improve and personalize diagnosis, survival 
analysis, and treatment of cancer patients. These include 
linear and non-linear, as well as supervised and unsupervised 
techniques like regression, principal component analysis (PCA), 
support vector machines (SVMs), deep neural networks, and 
autoencoders (Kourou et al., 2015).
Some are more suitable for integrating diverse types of data 
than others. In our work we use VAEs and combine them into 
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a number of different architectures for a deep analysis and 
comparison with respect to specific data features and tasks at 
hand. VAEs are particularly suitable in this setting since they 
are generative, non-linear, unsupervised, and amenable to 
integrating diverse data.
We deploy our architectures on the case of integrating multi-
omic and clinical cancer data. There are a number of candidate 
initiatives for big data collection of cancer data such as The 
Cancer Genome Atlas (TCGA) and METABRIC. In our work 
we use the METABRIC data set because it is one of the largest 
among genetic data sets, it is reasonably well annotated, and it is 
well analyzed. We particularly focus on the integration of gene 
expressions, copy number alterations, and clinical data.
In this section we describe theoretical aspects of VAEs and the 
specialized architectures that we use to integrate data. Next, we 
describe the data and the suite of experiments used to evaluate the 
methodological and computational frameworks for investigating 
cancer traits in clinical applications.
Variational Autoencoders
Generally, an autoencoder consists of two networks, an encoder 
and a decoder, which broadly perform the following tasks:
• Encoder: Maps the high dimensional input data into a latent 
variable embedding which has lower dimensions than the input.
• Decoder: Attempts to reconstruct the input data from 
the embedding.
The model contains a decoder function f (·) parameterized by 
θ and an encoder function g(·) parameterized by ϕ. The lower 
dimensional embedding learned for an input x in the bottleneck 
layer is h = gϕ(x) and the reconstructed input is x’ = fθ(gϕ(x)).
The parameters 〈θ,ϕ〉 are learned together to output a 
reconstructed data sample that is ideally the same as the original 
input x ≈ fθ(gϕ(x)). There are various metrics used to quantify the 
error between the input and output such as cross entropy (CE) or 
simpler metrics such as mean squared error:
 
L
nAE i i
i
n
( , ) ( ( ( ))) .θ φ φ= −
=
∑1 0 2
0
x f g x
 
The main challenge when designing an autoencoder is its 
sensitivity to the input data. While an autoencoder should learn 
a representation that embeds the key data traits as accurately 
as possible, it should also be able to encode traits which 
generalize beyond the original training set and capture similar 
characteristics in other data sets.
Thus, several variants have been proposed since autoencoders 
were first introduced. These variants mainly aim to address 
shortcomings such as improved generalization, disentanglement, 
and modification to sequence input models. Some significant 
examples include the Denoising Autoencoder (DAE) (Vincent et al., 
2008), Sparse Autoencoder (Coates et al., 2011; Makhzani and Frey, 
2014), and more recently the VAE (Kingma and Welling, 2014).
The VAE (Figure 1) uses stochastic inference to approximate the 
latent variables z as probability distributions. These distributions 
represent and capture relevant features from the input. VAEs are 
scalable to large data sets, and can deal with intractable posterior 
distributions by fitting an approximate inference or recognition 
model, using a reparameterized variational lower bound estimator. 
They have been broadly tested and used for data compression 
or dimensionality reduction. Their adaptability and potential 
to handle non-linear behavior has made them particularly well 
suited to work with complex data.
A VAE builds upon a probabilistic framework where the 
high dimensional data x is drawn from a random variable with 
distribution pdata(x). It assumes that the natural data x also lies 
in a lower dimensional space, that can be characterized by an 
unobserved continuous random variable z. In the Bayesian 
approach, the prior pθ(z) and conditional (or likelihood) pθ(x|z) 
FIgURe 1 | The unimodal Variational Autoencoder (VAE) architecture and 
latent embedding: the red layers correspond to the input and reconstructed 
data, given and generated by the model. The hidden layers are in blue, with 
the embedding framed in black. Each latent component is made of two 
nodes (mean and standard deviation), which define a Gaussian distribution. 
The combination of all Gaussian constitutes the VAE generative embedding.
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typically come from a family of parametric distributions, with 
Probability Density Functions differentiable almost everywhere 
with respect to both θ and z. While the true parameters θ 
and the values of the latent variables z are unknown, the VAE 
approximates the often intractable true posterior pθ(x|z) by 
using a recognition model qθ(z|x) and the learned parameters ϕ 
represented by the weights of a neural network.
More specifically, a VAE builds an inference or a recognition 
model qθ(z|x), where given a data-point x it produces a distribution 
over the latent values z from where it could have been drawn. 
This is also called a probabilistic encoder. A probabilistic decoder 
will then, given a certain value of z, produce a distribution over 
the possible corresponding values of x, therefore constructing 
the likelihood pθ(x|z). Note that the decoder is also a generative 
model, since the likelihood pθ(x|z) can be used to map from the 
latent to the original space and learn to reconstruct the inputs as 
well as generate new ones.
Typically, VAE model assumes latent variables to be the 
centred isotropic multivariate Gaussian pϕ(z) = N(z;0, I), 
and pθ(x|z) a multivariate Gaussian (for numerical values) or 
Bernoulli (for categorical values) with parameters approximated 
by using a fully connected neural network. Since the true 
posterior pθ(z|x) is intractable, we assume it takes the form of 
a Gaussian with an approximately diagonal covariance. This 
allows the variational inference alternative to approximate 
the true posterior, as it converts the inference problem into an 
optimization one. In particular, instead of solving intractable 
integrals, this relates to maximizing a likelihood. In such cases, 
the variational approximate posterior will also need to be a 
multivariate Gaussian with diagonal covariate structure:
 
q z x N z Ii i iφ µ σ| ; ,( ) ( ) ( )( ) ( )=  
where the mean μ(i) and standard deviation σ(i) are outputs of 
the encoder.
Since pθ(z) and qϕ(z|x(i)) are Gaussian, the discrepancy 
between them can be directly computed and differentiated. The 
resulting likelihood for this model on data-point x(i) is:
 
l i q i( , ) [log ( | )] KL( ( | )|( | )
(i)
( )θ φ φ θ φ= − +E p x z q z xz x | ( )),p zθ  
where the first term corresponds to the reconstruction 
loss, which encourages the decoder to learn to reconstruct 
the data from the embedding space. The second term is 
regularization, and measures the divergence between the 
encoding distributions q(z|x) and p(z), and penalizes the 
entanglement between components in the latent space. It is 
typically estimated by the Kullback–Leibler (KL) divergence, a 
measure of discrepancy between two probability distributions, 
which in this case is applied between the prior and the 
representation.
While in this paper we focus on a standard Gaussian prior 
due to its simplicity, there are several, more sophisticated, 
alternatives for the choice of a prior. In particular, Dilokthanakul 
et al. (2016) propose a mixture of Gaussians in order to achieve 
more flexible priors, and Tomczak and Welling (2018) realize 
this by estimating the prior as a mixture of approximate 
posteriors. Nalisnick and Smyth (2017) employ a Dirichlet 
process as a non-parametric prior through stick-breaking 
process, which generalizes over the generative process and 
allows for better representations. Johnson et al. (2016) utilize 
graphical models as a prior to train a VAE model. These 
alternative approaches to the choice of a prior require more 
sophisticated model training techniques in the learning phase. 
On the other hand, there are also approaches that instead of 
the prior, they focus on more flexible posteriors, therefore 
leading to better (and disentangled) representations. These 
include normalizing flows (Rezende and Mohamed, 2015), 
auto-regressive flows (Chen et al., 2017), and inverse auto-
regressive flows (Kingma et al., 2016).
In a similar context, research has shown that the entanglement 
factor can play a crucial role in the quality of the representations. 
In response, Higgins et al. (2017) control the influence of the 
disentanglement factor using a parameter β. Moreover, some 
approaches have experimented with different regularization 
terms, such as the InfoVAE (Zhao et al., 2017), where Maximum 
Mean Discrepancy (MMD) is employed as an alternative to KL 
divergence. MMD (Gretton et al., 2007) is based on the concept 
that two distributions are identical if, and only if. all their moments 
are identical. Therefore, by employing MMD via the kernel 
embedding trick, the divergence can be defined as the discrepancy 
between the moments of two distributions p(z) and q(z) as:
 
MMD q z p z Ep z p z
q z z
( ( )|| ( )) ( ), ( )[ ( , )]
E ( ), (
=
′
′
+
′
k z z
q )[ ( , )] ( ), ( )[k( , )]k z z E z p z z z′ − ′ ′2 q  
where k(z,z’) denotes any universal kernel (Zhao et al., 2019). In 
this paper, we employ a Gaussian kernel k z
z z
( , )
|| ||
z e′ =
−
− ′
2
22σ  when 
considering MMD regularization in the objective function.
Variational Autoencoders for Data 
Integration
We designed and evaluated four different architectures for data 
integration: we present them here each with two diverse data 
sources (depicted in Figures 2, 3, 4, and 5 as red and green boxes 
on the left).
The first architecture, Variational Autoencoder with 
Concatenated Inputs (CNC-VAE) in Figure 2, is a simple 
approach to integration, where the encoder is directly trained 
from different data sets, aligned, and concatenated at input. 
While such architecture is a straightforward and not a novel 
way to data integration, we employ it both, as a benchmark and 
a proof-of-principle for learning a homogeneous representation 
from heterogeneous data sources.
Besides the concatenated input, the rest of the CNC-VAE 
network utilizes a standard VAE architecture. As depicted in 
Figure 2, the input data is first scaled, aligned, and concatenated 
before being fed to the network. CNC-VAE has one objective 
function that reconstructs the combined data rather than a 
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separate objective function for each input data source. Therefore, 
CNC-VAE aims at reducing redundancies and extracting 
meaningful structure across all input sources, regardless of the 
scales or modalities of the data. While the CNC-VAE architecture 
may be simplistic, the complexity lies in highly domain-specific 
preprocessing of the data. Indeed, in some real-world settings, 
utilizing a single objective function of combined heterogenious 
inputs may not be optimal or even feasible.
Unlike CNC-VAE, the next three architectures aim at 
more sophisticated means to data integration. In particular, 
all of them consider data integration in the hidden layers. The 
X-shaped Variational Autoencoder (X-VAE) merges high-
level representations of several heterogeneous data sources into 
a single latent representation by learning to reconstruct the 
input data from the common homogeneous representation. The 
architecture is depicted in Figure 3 and consists of individual 
branches (one for each data source: red and green) that are 
combined into one before the bottleneck layer. In the decoding 
phase, the merged branch splits again into several branches 
that produce individual reconstructions of the inputs. X-VAE 
takes into account different data modalities by combining 
different loss functions for each data source in the objective 
function. This allows for learning better and more meaningful 
representations.
While, in principle, X-VAE is able to take into account 
many possible interactions between multiple data sources, 
its performance is sensitive to the properties of the data being 
integrated. In particular, X-VAE is prone to poor performance 
FIgURe 2 | The Variational Autoencoder with Concatenated Inputs (CNC-
VAE) Architecture: the red and green layers on the left correspond to two 
inputs from different data sources. The blue layers are shared, with the 
embedding being framed in black.
FIgURe 3 | The X-shaped Variational Autoencoder (X-VAE) Architecture: the 
red and green layers on the left correspond to two inputs from different data 
sources. The blue layers are shared, with the embedding being framed in black.
FIgURe 4 | The Mixed-Modal Variational Autoencoder (MM-VAE) 
Architecture: the red and green layers on the left correspond to two inputs 
from different data sources. The blue layers are shared, with the embedding 
being framed in black.
FIgURe 5 | The Hierarchical Variational Autoencoder (H-VAE) Architecture: 
the red and green layers on the left correspond to two inputs from different 
data sources. The blue layers are shared, with the embedding being framed 
in black.
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when employed to integrate unbalanced data sets with low 
number of observations. As a consequence, the objective function 
might also be unbalanced, focusing on some sources more if the 
distribution of the input data varies substantially across the data 
sources. A similar limitation can also result from a poor choice of 
loss function for each of the data sources.
The Mixed-Modal Variational Autoencoder (MM-VAE) 
attempts to address some of the limitations of X-VAE, by 
employing a more gradual integration in the hidden layers of 
the encoder. More specifically, it builds upon the concept of 
transfer learning, where learned concepts from one domain are 
re-purposed and shared for learning tasks in others domains. 
Figure 4 presents the architecture of MM-VAE. Similarly to 
X-VAE, it also consists of branches that individually reconstruct 
the input data sources. Here, however, the important difference 
is that the branches share information with each other in the 
encoding phase. In particular, higher-level learned concepts of 
each branch are shared between all the branches, and used deeper 
in the network. This allows for information from the different 
sources to be combined more gradually before being compressed 
into a single homogeneous embedding.
The objective function combines different reconstruction loss 
functions that correspond to the data types at input. Similarly 
to X-VAE, MM-VAE’s performance is limited when small and 
unbalanced data sets are being considered. While the additional 
integration layers may help to stabilize the objective function, 
poor choice of reconstruction loss terms may still impede the 
performance in general.
The Hierarchical Variational Autoencoder (H-VAE) builds 
upon traditional meta-learning approaches for combining 
multiple individual models. H-VAE, depicted in Figure 5, is 
comprised of several low-level VAEs that relate to each data 
source separately, and the result is assembled together in a 
high-level VAE. More specifically, each of the low-level VAEs is 
employed to learn a representation of an individual data source. 
These individual representations are then merged together 
and fed to a high-level VAE that produces the integrated data 
representation. We use the same architecture for each low-level 
VAE, but in principle, these could be independently designed 
and further refined for a specific data-source and task at hand.
H-VAE is designed to improve on some of the shortcomings 
of X-VAE and MM-VAE, since it simplifies the individual 
network branches. In particular, the input to the high-level 
autoencoder is composed of representations learned from several 
individual low-level autoencoders. These low-level autoencoders 
already implement distribution regularization terms in each of 
them separately, thus the input to the high-level autoencoder 
already consists of approximated multivariate standard normal 
distributions characterizing the general traits of the individual 
input modalities. Moreover, since each data source is handled in a 
modular fashion, H-VAEs are capable of handling data sets which 
make best use of specialized low-level autoencoders. However, 
constructing an H-VAE adds a substantial computational 
overhead compared to the other three architectures as it involves 
a two-stage learning process where low-level VAEs must be 
trained first, and then the final high-level representation can be 
learned on the outputs of the low-level encoders.
Data
To demonstrate how the proposed VAE architectures can be 
utilized in the integration of heterogeneous cancer data types, we 
conducted our study utilizing multi-omics data found on somatic 
copy number aberrations (CNA), mRNA expression data, as well 
as on the clinical data of breast cancer patient samples from the 
METABRIC cohort (Curtis et al., 2012).
Providing effective treatment takes such heterogeneity of data 
into account, and our VAE architectures enable us to do just 
that. Finding driver events which help stratify breast cancers into 
different subgroups has been of great focus within the research 
community lately, particularly the identification of genomic 
profiles that stratify patients.
In the context of genomic and transcriptomic studies, 
the acquired somatic mutations and the inherited genomic 
variation contribute jointly to tumorigenesis, disease onset, and 
progression (Curtis et al., 2012; Tan et al., 2015; Pereira et al., 
2016). For example, despite somatic CNAs being the dominant 
feature found in sporadic breast cancer cases, the elucidation of 
driver events in tumorigenesis is hampered by the large variety of 
random non-pathogenic passenger alterations and copy number 
variants (Leary et al., 2008; Bignell et al., 2010).
This has led to the argument that integrative approaches 
for the available information are necessary to make richer 
assessments of disease sub-categorization (Curtis et al., 2012). A 
pioneering work that advocates this perspective in breast cancer 
research is the METABRIC initiative. The METABRIC project is a 
Canada–UK initiative that aims to group breast cancers based on 
multiple genomic, transcriptomic, and image data types recorded 
over 2000+ patient samples. This data set represents one of the 
largest global studies of breast cancer tissues performed to date. 
Similarly to (Curtis et al., 2012) we focus on integrating CNA and 
mRNA expression data, but in addition integrate clinical data 
too. We use integrative VAEs to showcase how such architectures 
can be designed, built, and used for cancer studies of this kind.
experimental setup
What follows is an outline of our experimental evaluation used to 
verify that the studied approaches produce valid representations 
and can be employed for data integration. The aim of this evaluation 
is threefold. First, for each of the architectures, we seek the optimal 
configuration in terms of choosing an appropriate objective function 
and parameters of the network. Second, we aim to evaluate and 
choose the most appropriate architectures for our data-integration 
tasks. In particular, we perform a comparative quantitative analysis 
of the representations obtained from each of the architectures based 
on different data sets at input. Finally, we discuss the findings in 
terms of their application to cancer data integration and provide a 
qualitative (visual) analysis of the obtained representations.
In particular, we tackle several classification tasks by 
integrating three data types from the METABRIC data—CNA, 
mRNA expression, and clinical data. We evaluate the predictive 
performance of the integrative approaches by combining clinical 
and mRNA data, CNA and mRNA data as well as clinical and 
CNA data, separately. The METABRIC data consists of 1,980 
breast-cancer patients assigned to different groups according to:
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• two immunohistochemistry (IHC) sub-types (ER+ and ER−),
• six intrinsic gene-expression sub-types (PAM50) (Prat et al., 
2010), and
• 10 IntegrativeCluster (IntClust) sub-types (Curtis et al., 2012).
These patients are also assigned to two groups based on 
whether or not the cancer metastasised to another organ after 
the initial treatment (i.e., Distance Relapse). The three cancer 
sub-types and the distance relapse variable (described with gene 
expression profiles, CNA profiles, and clinical variables for each 
patient), are used as target variables in the classification tasks 
performed in the study.
To control our study, we followed Curtis et al. (2012) and 
used a pre-selected set of the input CNA and mRNA features. 
In particular, we used the most significant cis-acting genes 
that are significantly associated with CNAs determined by a 
gene-centric ANOVA test. We selected the genes with the most 
significant Bonferroni adjusted p-value from the Illumina 
database containing 30,566 probes. After missing-data removal, 
the input data sets consisted of 1000 features of normalized gene 
expression numerical data, scaled to [0,1], and 1000 features of 
copy number categorical data. The clinical data included various 
categorical and numerical features such as: age of the patient at 
diagnosis, breast tumor laterality, the Nottingham Prognostic 
Index, inferred menopausal state, number of positive lymph 
nodes, size and grade of the tumor, as well as chemo-, hormone-, 
and radio-therapy regimes. Numerical features were discretized 
and subsequently one-hot encoded. This was combined with the 
categorical features, yielding 350 clinical features. Finally, all three 
data sets were sampled into five-fold cross-validation splits for 
each classification tasks separately, stratified according to the class 
distribution of the four target variables, respectively. Note that 
these splits remained the same for all experiments in the study.
While our four architectures differ in some key aspects related 
to how and where (on which level) they integrate data, for 
experimental purposes of this study, the depth of the architectures 
remained moderate, and constant across all experiments. In 
particular, in all designs except for MM-VAE, the encoder 
and decoder were symmetric and consisted of compression/
decompression dense layers placed before and after data merging. 
MM-VAE implemented an additional data-merging layer in 
the encoder network. Therefore, all of the architectures had a 
moderate depth between two and four hidden layers. The optimal 
output size of these layers was evaluated for different values of 
128,256 and 512. Moreover, all layers used batch normalization 
(Ioffe and Szegedy, 2015) with Exponential Linear Unit (Clevert 
et al., 2016) activations (except for the bottleneck and the output 
layers). All of the architectures also employed a hidden dropout 
component with a rate of 0.2. Note that the final layers of the CNA 
and clinical branches employed sigmoid activation function. The 
models were trained for 150 epochs using an Adam optimizer 
(Kingma and Ba, 2015) with a learning rate of 0.001 (with 
exponential decay rates of first- and second-moment estimates β1 
= 0.9 and β2 = 0.999) and a batch size of 64. Furthermore, we also 
investigated the performance of representations with different 
sizes. For each of the architectures and their configurations, we 
learned and evaluated representations with sizes 16, 32, and 64.
In the experiments we also considered choosing an optimal 
objective function that would improve the disentanglement 
between the embedded components. The objective functions 
consider both the reconstruction loss and a regularization 
term. For the former, given that we integrated heterogeneous 
data, we incorporated Binary Cross Entropy loss for the 
categorical and Mean Squared Error loss for the continuous 
data. Note that, while the CNA data is categorical and so 
multivariate categorical distribution would be suitable, an 
approach such as one-hot encoding would substantially 
increase the data dimensionality. Therefore, we employed 
label smoothing (Salimans et al., 2016), where the form 
of pθ(xcna|z) is a multivariate Bernoulli distribution, with 
values of xcna scaled to [0,1]. For the regularization terms, 
we evaluated different options which include weighted KL 
divergence and weighted MMD. We tested different values 
of weight β, β∈{1,10,15,25,50,100}, for each of the two 
regularization terms.
To make optimal design decisions, we evaluated the quality 
of the representations obtained from our four integrative 
architectures on three integrative tasks, each of these with 108 
different network configurations with respect to the hyper-
parameters outlined above. In particular, we evaluated the 
performance of a given configuration by training a predictive 
model on the produced representations and measuring its 
predictive performance on a binary classification task of IHC 
cancer sub-types (ER+ and ER−). For all network configurations, 
we trained and evaluated a Gaussian naive Bayes classifier, since 
it does not require tuning of additional hyper-parameters for the 
downstream task. We performed a five-fold cross-validation and 
report the average accuracy.
Once we identified the appropriate configuration for each 
of the architectures, we evaluated the quality of the learned 
representation in terms of predictive performance on the 
remaining three classification tasks. In particular, we evaluated 
the performance of three different methods trained on different 
representation. These included Gaussian naive Bayes classifier, 
SVMs (with RBF kernel C = 1.5 and gamma set to 1/Nf, where 
Nf denotes the number of features) and Random Forest (with 50 
trees and 1/2 of the features considered at every split). For all three 
classification tasks we also performed a five-fold cross-validation 
and report the average accuracy. We also compared these results 
with the performance of predictive models trained on: (i) the raw 
(un-compressed) data, as well as (ii) data transformed using PCA 
(a linear method for data transformation).
The integrative VAE architectures are implemented using the 
Keras deep learning library (Chollet et al., 2015) with Tensorflow 
backend. The code for training and evaluating the performance 
of the VAE networks is available on this repository.1
Finally, we visually inspected the learned representations of 
the whole data set obtained from each of the architectures, and 
compared them to the uncompressed data. For this task we 
employed the t-distributed stochastic neighboring embedding 
(tSNE) (van der Maaten and Hinton, 2008) algorithm.
1 https://github.com/CancerAI-CL/IntegrativeVAEs 
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ResUlTs
We present and discuss the results of the empirical evaluation. 
First, we report on the analyses for identifying the suitable design 
choices within the integrative approaches. Next, we present the 
results of the analyses of predictive performance of three different 
predictive methods applied to representations obtained from our 
VAE architectures with the optimal configuration. Finally, we 
present a visual analysis of the learned representations obtained 
from the evaluated architectures.
Design of Integrative VAes
For each integrative task, we investigated 108 different 
configurations for each architecture. These highlighted the 
effect of the size of the learned embedding, the optimal size of 
each of the dense layers, the most appropriate regularization 
in the objective function, and how much this regularization 
should influence the overall loss. We evaluated these 
configurations for all four architectures on three integrative 
tasks, by comparing the average train and test performance 
of classifying IHC sub-typed patients. The results, in general, 
indicate that properties of these configurations for each 
architecture are consistent across the three integrative tasks. 
Therefore, for brevity, here we only present the results when 
combining clinical and mRNA data. The rest of the results, 
namely for combining CNA and mRNA, and CNA and clinical 
data are given in the Supplementary Material.
Figure 6 presents the downstream performance of predictive 
models, trained on the representations produced by the 
integrative VAEs on clinical and mRNA data. In particular, 
Figures 6A–D compare the performance from representations 
obtained from CNC-VAE, X-VAE, MM-VAEm and H-VAE, 
respectively. In general, the configurations regularized with 
MMD yield better representations that lead to substantially 
more accurate predictions than the configurations regularized 
with KL. In terms of the weight of the regularization term, the 
configurations are robust in general, with moderately large 
weights (β = [25,50]) leading to slightly better results.
In term of the size of the dense layers, all architectures except 
H-VAE exhibit stable behavior, with moderate sizes of (size = 
[128,256]) leading to slightly better representations than the ones 
with dense layer size of 512 in the case of X-VAE and MM-VAE. 
In the case of H-VAE, the quality of the representations is more 
affected by the size of the layer where smaller sizes lead to better 
performance than larger ones.
Considering the size of the latent space, the networks that 
produce higher-dimensional encodings lead to better predictive 
performance. This is particularly the case for X-VAE and 
MM-VAE architectures, while the other two are mostly unaffected. 
Note however, that the influence of the size of the representations 
on the overall performance is also related to the integrative task. 
More specifically, for this particular classification task, higher-
dimensional representations when integrating clinical and 
mRNA data yield better and more stable performance overall. 
In contrast, when integrating clinical/CNA or CNA/mRNA data 
lower-dimensional representations are better.
In summary, based on these results, we made the following 
design decisions for configuring the integrative VAE 
architectures for the rest of the experimental analyses. First, the 
networks were trained using the MMD regularization with β = 
50, since in all cases using MMD exhibited better performance 
than the networks trained using KL divergence with various 
levels of β. Next, we set the size of the dense layers to 256. Finally, 
since large sizes of the latent space yielded better performance, 
we set it to be 64.
Quality of the learned Representations
In this set of experiments, we focused on testing our central 
hypothesis that the integrative VAE architectures are able 
to produce representations that yield stable and improved 
predictive performance. We evaluated their performance in 
three classification tasks: predicting IC10, PAM50 sub-types, and 
Distance Relapse.
We used three standard predictive methods: Naive Bayes, SVM, 
and Random Forest. These were deployed: (i) on representations 
learned (compressed) from data integrated through our four 
VAE architectures; (ii) on embedded combined data using PCA 
with 64 components; (iii) on combined raw (un-compressed) 
data; and (iv) on each of the data sources separately in order to 
evaluate the integrative effect. Apart from this last case, the data 
sources for integration were CNA/mRNA, clinical/mRNA, and 
clinical/CNA data, as before.
Table 1 summarises the results of this analysis. In general, all 
of the VAE integrative architectures outperform the baselines on 
all three predictive tasks when integrating CNA/mRNA, clinical/
mRNA data, and clinical/CNA. Overall, all architectures produce 
better representations when integrating clinical and mRNA data. 
This result is consistent across all three tasks, where the learned 
representations coupled with SVMs yield the best predictive 
performance. This finding is also supported by the benchmark 
approaches, where combining clinical and mRNA data yields 
better results than CNA/mRNA and clinical/CNA. Note that, for 
the task of predicting Distance Relapse, integrating clinical/CNA 
exhibits, in general, slightly worse but comparable performance 
to the one produced for clinical/mRNA. These results suggest 
that for our particular classification tasks, some data types are 
more beneficial to integrate than others.
We note that while VAEs lead to more accurate predictions, 
this performance improvement is not significant when 
compared to PCA. We conjecture that this might be an artifact 
of many linear relations present in the data, which are captured 
by the PCA. In contrast, the integrative VAEs are also able 
to model the non-linearities in the data, which gives them a 
performance advantage.
Comparing the performance of the four VAE architectures, 
H-VAE and X-VAE mostly yield more accurate predictions, 
however, the difference is not significant. Overall, for these 
three tasks, H-VAE produces more stable and better quality 
predictions when applied for integrating clinical and mRNA 
data, given the design decisions outlined previously. While for 
simplicity we made the same design choices for all architectures, 
the performance of these models can be further improved, with 
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FIgURe 6 | Comparison of the downstream performance on the IHC classification tasks of a predictive model trained on the representations produced by integrating 
clinical and mRNA data using (A) CNC-VAE, (B) X-VAE, (C) MM-VAE, and (D) H-VAE. Full circles denote the training accuracy, while empty circles and bars denote 
the test accuracy averaged over five-fold cross-validation. Red and blue colors denote the configurations when Maximum Mean Discrepancy (MMD) and Kullback–
Leibler (KL) are employed, respectively. Bottom x-axis depicts the size of the latent dimension, while the top x-axis the size of the dense layers of each configuration.
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careful calibration of both the architecture components as well 
as the hyper-parameters of the classifier considered.
Qualitative Analyses
In the last set of experiments, we visually inspected the learned 
representations of the whole data set, obtained from the H-VAE 
by integrating clinical/mRNA data. Using tSNE diagrams, shown 
in Figure 7, we compared the level of disentanglement of the 
embedded data with both, raw (uncompressed) data as well 
as PCA-transformed data. The tSNE projections clearly show 
that H-VAE is able to produce more sparse and disentangled 
representations in comparison to raw or PCA transformed data. 
Note that the t-SNE projections of the raw and PCA-transformed 
data also indicate data separability. This may explain the 
competitive performance produced by the benchmark classifiers 
in the previous section, as well as the advantage of integrating 
clinical and mRNA data.
DIsCUssION
In this study we investigated and evaluated aspects of VAE 
architectures important for integrative data analyses. We 
designed and implemented four integrative VAE architectures, 
and demonstrated their utility in integrating multi-omics and 
clinical breast-cancer data. We systematically experimented 
(we evaluated 1296 different network configurations) with 
how the data should be integrated as well as what appropriate 
architecture parameters produce high-quality, low-dimensional 
representations. In the case of integrating breast-cancer data 
we found that the choice of an appropriate regularization when 
training the autoencoders is imperative. Our results show that 
the integrative VAEs yield better (and more disentangled) 
representations when MMD is employed, which also corresponds 
to findings from other studies (Zhao et al., 2017; Chen et al., 
2018). Moreover, we found that giving a moderately large weight 
to this regularization term further improves the quality of the 
learned representations. The results show that the quality of the 
representations is mostly invariant to the size of the hidden layers 
and the embedding dimension, suggesting that the investigated 
integrative architectures are robust. Note however, that such 
parameters are task-specific, and therefore it is recommended 
that they are tuned according to the dimensionality of the input 
data as well as the depth of the network.
In the context of performance, all four integrative VAE 
architectures are generally able to produce better representations 
of the data when compared to a linear transformation approach. 
This suggests that the integrative VAEs are able to accurately 
model the non-linearities present in the integrated data, while 
still being able to reduce the data-dimensionality, leading to good 
representations. When comparing the different architectures, 
the results showed that overall the H-VAE and X-VAE exhibit 
the best performance, followed by the simple CNC-VAE and 
MM-VAE. This indicates that, while all of the architectures are 
able to accurately model the data, H-VAE exhibits more stable 
behavior. Moreover, given that H-VAE is a hierarchical model, 
TABle 1 | Comparison of the downstream predictive performance (on three classification tasks) of the three predictive models trained on raw and PCA-transformed 
data as well as representations produced by the four integrative Variational Autoencoders (VAEs) by integrating copy number aberration (CNA)/mRNA, clinical/mRNA, 
and clinical/CNA data.
DR PAM50 IC10
NB sVM RF NB sVM RF NB sVM RF
CNC-VAE CNA + mRNA 0.648 0.687 0.684 0.731 0.789 0.749 0.742 0.823 0.784
Clin. + mRNA 0.732 0.750 0.711 0.784 0.827 0.750 0.829 0.834 0.781
Clin. + CNA 0.682 0.751 0.711 0.563 0.624 0.503 0.612 0.657 0.485
X-VAE CNA + mRNA 0.639 0.687 0.685 0.715 0.788 0.751 0.747 0.835 0.785
Clin. + mRNA 0.751 0.774 0.735 0.787 0.816 0.758 0.821 0.858 0.781
Clin. + CNA 0.695 0.772 0.724 0.576 0.628 0.517 0.627 0.679 0.487
MM-VAE CNA + mRNA 0.659 0.693 0.688 0.739 0.774 0.759 0.774 0.841 0.799
Clin. + mRNA 0.744 0.756 0.731 0.803 0.800 0.760 0.824 0.838 0.781
Clin. + CNA 0.746 0.770 0.732 0.587 0.605 0.508 0.604 0.621 0.477
H-VAE CNA + mRNA 0.656 0.687 0.683 0.724 0.792 0.744 0.746 0.816 0.792
Clin. + mRNA 0.748 0.774 0.746 0.790 0.827 0.768 0.794 0.839 0.776
Clin. + CNA 0.728 0.761 0.732 0.525 0.579 0.469 0.477 0.594 0.393
PCA CNA + mRNA 0.628 0.694 0.682 0.595 0.696 0.632 0.639 0.766 0.675
Clin. + mRNA 0.729 0.754 0.724 0.708 0.771 0.693 0.761 0.828 0.702
Clin. + CNA 0.673 0.745 0.733 0.562 0.621 0.560 0.601 0.669 0.606
Raw data CNA + mRNA 0.618 0.696 0.677 0.528 0.581 0.730 0.723 0.664 0.763
Clin. + mRNA 0.754 0.696 0.748 0.492 0.596 0.739 0.344 0.530 0.780
Clin. + CNA 0.757 0.696 0.763 0.407 0.539 0.617 0.517 0.615 0.646
Raw data Only CNA 0.609 0.696 0.647 0.430 0.523 0.568 0.621 0.604 0.624
Only mRNA 0.612 0.696 0.687 0.646 0.604 0.730 0.769 0.633 0.774
Only clinical 0.757 0.708 0.747 0.265 0.363 0.437 0.110 0.181 0.259
Italic typeface denotes the best performance obtained by a particular method for a particular classification task. Bold typeface denotes the best-performing method for the particular 
classification task.
CNC-VAE, Variational Autoencoder with Concatenated Inputs; X-VAE, X-shaped Variational Autoencoder; MM-VAE, Mixed-Modal Variational Autoencoder; H-VAE, Hierarchical 
Variational Autoencoder.
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all of the learned representations (including the intermediate 
ones from the low-level autoencoders) can be further utilized 
for more delicate, interpretable analyses. Note however, when 
employing H-VAE, there is a trade-off between the quality of the 
learned representations and the time required for learning them. 
Therefore, when time or resources are limited, employing X-VAE 
or even the simple CNC-VAE will yield favourable results.
In terms of integrative analyses of breast-cancer data, the 
results indicate that, for the particular classification tasks 
considered in our study, some data types are more amenable 
to integrating than others. More specifically, utilizing the VAEs 
for integrating clinical and mRNA data coupled with the right 
classification method led to better downstream predictive 
performance than the alternative integration of CNA and mRNA 
data. This highlights an important aspect of this study: for 
premium results in such integrative data analyses, one should 
not only focus on the choice and tuning of appropriate predictive 
methods, but also on the type of data at input. In other words, 
rather than considering separate components of the analysis, one 
should focus on the whole end-to-end integrative process.
Autoencoders have been used for learning representations and 
analyzing transcriptomic cancer data before. In particular, our 
work relates to Way and Greene (2018), since it employs VAEs for 
constructing latent representations and analyzing transcriptomic 
cancer data. The authors show that VAEs can be utilized for 
knowledge extraction from gene expression pan-cancer TCGA 
data (TCGA et al., 2013), thus reducing the dimensionality of 
the single, homogeneous data source while still being able to 
identify patterns related to different cancer types. Our work is 
also related to Tan et al. (2015), where the authors deploy DAE 
for integrating and analyzing gene-expression data from TCGA 
(TCGA et al., 2013) and METABRIC (Curtis et al., 2012). Tan 
et al. (2015) also employ DAE for learning latent features from 
multiple data sets. The latent features are used to identify genes 
relevant to two different breast cancer sub-types.
In contrast to Curtis et al. (2012) and Tan et al. (2015), we 
designed novel VAE architectures for integrating heterogeneous 
data, hence enabling learning patterns that relate to the intrinsic 
relationships between different data types. While DAEs aim at 
learning an embedded representation of the input, the VAEs 
focus on learning the underlying distribution of the input data. 
Therefore, besides data integration, the methods proposed in this 
paper can be also employed for data generation.
More generally, our work relates to other approaches based 
on autoencoders for data integration on various tasks of cancer 
diagnosis and survival analysis. These include using DAEs for 
integrating various types of electronic health records (Miotto 
et al., 2016) as well as custom designed autoencoders for analyses 
of liver (Chaudhary et al., 2018), bladder (Poirion et al., 2018), 
and neuroblastoma (Zhang et al., 2018) cancer types.
In a broader context, our work is related to the long tradition 
of data integration approaches for addressing various challenges 
in cancer analyses. In particular, Curtis et al. (2012) present an 
approach for clustering breast-cancer patients based on integrated 
data from the METABRIC cohort. The approach uses the 
Integrative Clustering method (Shen et al., 2009) which produces 
clusters from a multi-omic joint latent embedding. These clusters 
are then utilized for identifying mutation-driver genes (Pereira 
et al., 2016) and survival analyses (Rueda et al., 2019). In this 
context, the work presented in this paper can be readily applied 
to similar tasks. In particular, the integrative VAEs can be used 
to learn common representations of the heterogeneous data 
at input, which can then be used for constructing clusters that 
address the aforementioned analysis tasks. In contrast to the 
Integrative Clustering method, the integrative VAEs can handle 
high-dimensional data sources, which provide better integration 
and therefore may further improve the overall performance.
In a similar context, the Similarity Network Fusionmethod 
by Wang et al. (2014) successfully addresses intermediate 
heterogeneous data integration for identifying cancer sub-types for 
various kinds of cancers including glioblastoma, breast, kidney, and 
lung carcinoma. Similarity Network Fusion first constructs graphs 
from the individual data sources, which are in turn combined into a 
single, integrative, graph using nonlinear similarity approach. Such 
graphs can be also used in conjunction with the integrative VAEs. 
More specifically, by using such graphs will impose a structure 
of the integrative data, which in turn may lead to far better (and 
disentangled) representations. Next, Gevaert et al. (2006) present 
a data integration approach with Bayesian networks for predicting 
breast cancer prognosis. The authors report that employing Bayesian 
FIgURe 7 | Qualitative comparison of the learned representations with H-VAE, raw data, and PCA-transformed data when integrating clinical and mRNA data.
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networks for intermediate integration yields better performance for 
the particular predictive task. Since our proposed VAE approaches 
address full data integration, they can also be readily used together 
with the aforementioned integrative approaches.
We identified several additional directions for future work. 
First, the experiments reported in this study are limited to 
integrating heterogeneous multi-omics data from two sources. 
While in principle the autoencoder designs allow for integrating 
heterogeneous data from many more sources simultaneously, we 
intend to empirically evaluate the generality of our approaches 
and extend them to other types of data such as imaging data. Next, 
considering the specific architecture decisions made in this paper, 
we plan to further refine the designed architecture and fine-tune 
the learning hyper-parameters in ordered to improve the quality 
of the learned representations. This includes experimenting with 
deeper architectures as well as implementing methods that allow 
for more sophisticated priors as well as methods that focus on 
more flexible posteriors (Rezende and Mohamed, 2015; Kingma 
et al., 2016). Finally, we intend to ensemble the various proposed 
architectures which should yield more stable and robust findings, 
and take a step further towards producing more meaningful and 
interpretable findings.
While VAEs are capable of generating useful representations 
for vast amounts of complex heterogeneous data, in terms 
of interpretability, the biological relevance of the learned 
representations has to be verified if they are to be used in clinical 
decision support systems. Previous work (Tan et al., 2015) has 
attempted to interpret latent features, wherein features which 
were most influential in deciding clinical phenomena such ER/
IHC status were extracted and identified. However, the actual 
interpretations of these features have received comparatively 
little attention. In order to interpret extracted VAE features 
and bring explanation to the learned representations, biological 
and biomedical ontologies such as gene ontology (GO2) have 
proven very useful (Titus et al., 2018; Way and Greene, 2018). 
An immediate continuation of the work presented in this paper 
is performing enrichment analysis on genes most related to 
each VAEs’ learned embedding to investigate the joint effects 
of various gene sets within specific biological pathways. Tools 
such as ShinyGo3 allow KEGG Pathway Mapping4, where the 
relationships between genes and human disease including 
various types of cancer can be identified. Using this approach 
to interpretability can potentially offer a qualitative metric to 
evaluate and compare different VAE architectures based on 
the biological relevance of the features extracted from learned 
representations to breast cancer and other cancer types in general.
CONClUsION
In conclusion, in this study we demonstrate the utility of VAEs 
for full data integration. The design and the analyses of different 
integrative VAE architectures and configurations, and in 
2 http://geneontology.org
3 http://bioinformatics.sdstate.edu/go/
4 https://www.genome.jp/kegg/pathway.html#mapping
particular their application to the tasks of integrative modeliing 
and analyzing heterogeneous breast cancer data, are the main 
contributions of this paper.
The studied approaches have several distinguishing 
properties. First, they are able to produce representations 
that capture the structure (i.e., intrinsic relationships between 
the data variables) of the data and therefore allow for more 
accurate downstream analyses. Second, they are able to reduce 
the dimensionality of the input data without loss of quality 
or performance. Therefore, in the process of compressing 
the input data, they can reduce noise implicitly present in 
the data. Third, they are modular and easily extendable to 
handle integration of a multitude of heterogeneous data sets. 
Next, while the integrative VAEs can be used as a data pre-
proccessing approach for learning representations, they can 
also be utilized in a more generative setting for producing 
surrogate data, which can be used for more in-depth analysis. 
Finally, we show that VAEs can be successfully applied to 
learn representations in complex integrative tasks, such as 
integrative analyses of breast cancer data, that ultimately lead 
to more accurate and stable diagnoses.
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